Showing results (1801-1810 of 3,014) with videos related to

Sort By:
Pageof 302
Cytokine|July 22, 2022
Distinct type I interferon responses between younger women and older men contribute to the variability of COVID-19 outcomes: Hypothesis generating insights from COVID-19 convalescent individualsClio P Mavragani, Charalampos Skarlis, Ioannis V Kostopoulos, et al.
Anticancer Research|April 22, 2011
Time to castration resistance is an independent predictor of castration-resistant prostate cancer survivalEvangelos Bournakis, Eleni Efstathiou, Andreas Varkaris, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|February 2, 2006
Effects of exercise rehabilitation program on heart rate recovery in patients with chronic heart failureStavros Dimopoulos, Maria Anastasiou-Nana, Dimitrios Sakellariou, et al.
Oncology|January 18, 2012
A risk-adapted strategy of adjuvant paclitaxel/carboplatin in early-stage ovarian cancer: time-dependent effect of 4 versus 6 cycles on outcomeAristotle Bamias, Christina Bamia, Alexandra Karadimou, et al.
Cancer|October 3, 2000
Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II studyC A Papadimitriou, L A Moulopoulos, G Vlahos, et al.
Oncology|May 8, 2001
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancerG Fountzilas, C Papadimitriou, G Aravantinos, et al.
European Journal of Haematology|February 13, 2001
Comparison of vincristine, carmustine, melphalan, cyclophosphamide, prednisone (VBMCP) and interferon-alpha with melphalan and prednisone (MP) and interferon-alpha (IFN-alpha) in patients with good-prognosis multiple myeloma: a prospective randomized study. Greek Myeloma Study GroupK Zervas, A Pouli, B Gregoraki, et al.
Cancer Chemotherapy and Pharmacology|June 17, 2005
Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancerE Briasoulis, E Samantas, H Kalofonos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 11, 2009
Survival effect of venous thromboembolism in patients with multiple myeloma treated with lenalidomide and high-dose dexamethasoneMaurizio Zangari, Guido Tricot, Latha Polavaram, et al.
Clinical Imaging|December 30, 2025
The current role of cryoablation in the management of soft tissue and bone tumors: A narrative reviewMarios Platon Dimopoulos, Nefeli Chaniotaki, Maria Papageorgiou, et al.
Pageof 302